Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Single Country
  • Asset Class: Equity
  • Geographic Focus: U.K.

Barclays GlobalAccess UK Alpha Fund

+ Add to Watchlist

BUKAIDS:ID

2.03 GBP

As of 10:44:00 ET on 05/26/2015.

Snapshot for Barclays GlobalAccess UK Alpha Fund (BUKAIDS)

Year To Date: +7.94% 3-Month: +2.61% 3-Year: - 52-Week Range: 1.73 - 2.05
1-Month: +0.74% 1-Year: +9.33% 5-Year: - Beta vs ISEQ: 0.57

Mutual Fund Chart for BUKAIDS

No chart data available.
  • BUKAIDS:ID 2.03
  • 1M
  • 1Y
Interactive BUKAIDS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for BUKAIDS

Barclays GlobalAccess UK Alpha Fund is an open-end fund incorporated in Ireland. The Funds objective is long-term capital growth primarily through investment in UK companies. The Fund invests primarily in common stock, preferred shares and securities convertible into common stock, of established companies domiciled in the UK or having significant operations in the UK.

Inception Date: 05-21-2012 Telephone: +44 207 116 9000
Managers: -
Web Site: www.barclaysinvestments.co.uk

Fundamentals for BUKAIDS

NAV (on 2015-05-26) 2.03
Assets (M) (on 2015-04-30) 90.20
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for BUKAIDS

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net (on 2015-03-02) 0.00
Dividend Yield (ttm) 1.88

Fees & Expenses for BUKAIDS

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.90
Redemption Fee 0.00
12b1 Fee -
Expense Ratio -

Top Fund Holdings for BUKAIDS

Filing Date: 03/31/2015
Name Position Value % of Total
GlaxoSmithKline PLC 207,455 3,206,736 3.763%
Vodafone Group PLC 1,412,490 3,113,481 3.654%
FTSE 100 IDX FUT Jun15 45 3,027,150 3.553%
BP PLC 680,887 2,973,604 3.490%
HSBC Holdings PLC 425,040 2,439,517 2.863%
Tesco PLC 921,396 2,228,627 2.615%
Barclays PLC 899,985 2,183,139 2.562%
Aviva PLC 390,214 2,108,131 2.474%
AstraZeneca PLC 44,652 2,065,602 2.424%
Lloyds Banking Group PLC 2,527,752 1,978,977 2.323%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil